Feed GOVX
GO

GeoVax Labs, Inc.

GOVX · NASDAQ

$0.46 -3.54% (-$0.02)
1M -35.52%
Market Cap $3.43M
P/E Ratio -
Div. Yield -
ROE 743.66%
Piotroski F-Score Weak
2/9
Valuation
89 /100
Cheap
P/B 1.95x
P/FFO N/A
P/S N/A
Growth
78 /100
Growing
Book val. growth 47.61%
Rev. growth 212.55%
FCF growth N/A
Profitability
-
N/A
Net margin N/A
Op. margin N/A
FCF margin N/A
Quality
0 /100
Poor
ROE 743.66%
ROA 439.95%
Asset turnover 0.00x
Debt
92 /100
Low
Current ratio 1.54x
Debt/Equity 0.18x
Net debt/EBITDA N/A
Stability
1 /100
Unstable
EPS volatility 89.07%
Profitable years 0
Beta 3.65x

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o GOVX
Online

O podjetju

GeoVax Labs (GOVX) is a biotechnology company focused on the development of vaccines for the prevention and treatment of infectious diseases, such as HIV/AIDS, Ebola, Zika virus, and others. Using its patented technological approach, GeoVax develops vaccines aimed at providing effective protection against dangerous pathogens. The company also focuses on vaccine development for emerging threats in public health, including COVID-19. GeoVax Labs (GOVX) shares could be suitable for investors seeking opportunities in the biotechnology sector with a focus on vaccine research and development.

V vašem jeziku še ni na voljo, zato je besedilo v angleščini.

Sector

Healthcare

Industry

Biotechnology

CEO

David Alan Dodd

Employees

19

Headquarters

Smyrna

Prihajajoči dogodki

12 NOV.

Earnings

Upcoming earnings report

60d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.